Beam Therapeutics Inc (BEAM)
21.27
-1.27
(-5.63%)
USD |
NASDAQ |
May 10, 16:00
21.27
0.00 (0.00%)
After-Hours: 17:37
Beam Therapeutics Total Assets (Quarterly): 1.360B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.360B |
December 31, 2023 | 1.460B |
September 30, 2023 | 1.291B |
June 30, 2023 | 1.354B |
March 31, 2023 | 1.332B |
December 31, 2022 | 1.342B |
September 30, 2022 | 1.350B |
June 30, 2022 | 1.418B |
March 31, 2022 | 1.453B |
December 31, 2021 | 1.474B |
September 30, 2021 | 1.157B |
Date | Value |
---|---|
June 30, 2021 | 893.08M |
March 31, 2021 | 693.24M |
December 31, 2020 | 451.68M |
September 30, 2020 | 278.27M |
June 30, 2020 | 299.98M |
March 31, 2020 | 322.64M |
December 31, 2019 | 156.10M |
September 30, 2019 | 170.55M |
June 30, 2019 | 180.55M |
December 31, 2018 | 167.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
156.10M
Minimum
Dec 2019
1.474B
Maximum
Dec 2021
921.86M
Average
1.224B
Median
Total Assets (Quarterly) Benchmarks
Eli Lilly and Co | 63.94B |
Moderna Inc | 16.73B |
Editas Medicine Inc | 440.35M |
Intellia Therapeutics Inc | 1.301B |
Perspective Therapeutics Inc | 97.89M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 446.31M |
Shareholders Equity (Quarterly) | 913.49M |
Current Ratio | 5.991 |